Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Weber

Showing results (1221-1230 of 1,322) with videos related to

Pageof 133
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Annals of Biomedical Engineering|October 11, 2018
Health-Related Quality of Life Following Concussion in Collegiate Student-Athletes With and Without Concussion HistoryM L Weber, R C Lynall, N L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 2013
Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574Christopher L Shaffer, Raymond S Hurst, Renato J Scialis, et al.
Nature Biotechnology|June 1, 2010
Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cellsZara Melkoumian, Jennifer L Weber, David M Weber, et al.
Contraception|April 24, 2004
Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancerBrian L Strom, Jesse A Berlin, Anita L Weber, et al.
Journal of the National Cancer Institute|September 2, 1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersT R Rebbeck, A M Levin, A Eisen, et al.
Nature Genetics|March 1, 1996
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusC M Phelan, T R Rebbeck, B L Weber, et al.
Journal of the National Cancer Institute|July 22, 2004
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersH Jernström, J Lubinski, H T Lynch, et al.
Advances in Therapy|April 30, 2010
PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseasesHerbert A Runnels, Gregory L Weber, Jing Min, et al.
BMC Bioinformatics|December 18, 2020
Menoci: lightweight extensible web portal enhancing data management for biomedical research projectsM Suhr, C Lehmann, C R Bauer, et al.
Pageof 133

Showing results (1221-1230 of 1,322) with videos related to

Sort By:
Pageof 133
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Annals of Biomedical Engineering|October 11, 2018
Health-Related Quality of Life Following Concussion in Collegiate Student-Athletes With and Without Concussion HistoryM L Weber, R C Lynall, N L Hoffman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 2013
Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574Christopher L Shaffer, Raymond S Hurst, Renato J Scialis, et al.
Nature Biotechnology|June 1, 2010
Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cellsZara Melkoumian, Jennifer L Weber, David M Weber, et al.
Contraception|April 24, 2004
Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancerBrian L Strom, Jesse A Berlin, Anita L Weber, et al.
Journal of the National Cancer Institute|September 2, 1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersT R Rebbeck, A M Levin, A Eisen, et al.
Nature Genetics|March 1, 1996
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locusC M Phelan, T R Rebbeck, B L Weber, et al.
Journal of the National Cancer Institute|July 22, 2004
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersH Jernström, J Lubinski, H T Lynch, et al.
Advances in Therapy|April 30, 2010
PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseasesHerbert A Runnels, Gregory L Weber, Jing Min, et al.
BMC Bioinformatics|December 18, 2020
Menoci: lightweight extensible web portal enhancing data management for biomedical research projectsM Suhr, C Lehmann, C R Bauer, et al.
Pageof 133